Mold-Tek Packaging Q1 FY27 Results: Revenue Crosses ₹300 Crore, PAT Rises 14%

What Happened ?

key details

Strong Growth Across Key Business Segments:

Mold-Tek Packaging reported healthy demand across most of its core packaging segments during Q1 FY27, supported by capacity expansion, customer additions and increasing adoption of value-added packaging solutions. Pharma Packaging emerged as the fastest-growing vertical, while Food & FMCG and Paint Packaging also delivered robust volume growth. Only the Lubricant Packaging segment experienced temporary weakness due to supply disruptions affecting customers.

Segment-wise Volume Performance

• Pharma Packaging recorded the strongest growth with 38.75% YoY volume expansion, reflecting rapid customer acquisition and increasing acceptance of the company’s pharmaceutical packaging solutions. 
• Food & FMCG Packaging delivered 26.20% YoY volume growth, supported by higher consumer demand and deeper penetration across existing and new customers. 
• Paint Packaging posted 10.82% YoY volume growth, benefiting from healthy demand and continued customer confidence in Mold-Tek’s packaging solutions. 
• Lube Packaging witnessed lower demand during the quarter as customers faced supply constraints caused by disruptions linked to the Iran conflict.

Hyderabad Plant Consolidation Improves Efficiency:

A key contributor to the company’s improved profitability was the consolidation of its Hyderabad manufacturing operations.

• During the past six months, Mold-Tek consolidated five manufacturing units into two major facilities located at Annaram and Sultanpur.
• The restructuring brought all printing activities under one roof, reducing inter-unit transportation, lowering overhead expenses and minimizing production rejections.
• Combined with improved capacity utilisation of around 75%, these operational efficiencies helped the company achieve a record EBITDA of ₹46.68 per kgduring the quarter. 

Capacity Expansion Across Pharma and Food Packaging:

To support growing demand, the company commissioned additional manufacturing capacity across multiple business segments.

Pharma Packaging

• Additional moulding machines and an assembly machine were commissioned during Q1 FY27.
• The expansion is expected to improve production capability and support increasing demand from pharmaceutical customers.
• The company is also planning to expand into ophthalmic packaging and medical device packaging, broadening its presence in higher-margin healthcare applications.

Food & FMCG Packaging

• Mold-Tek commissioned eight new injection moulding machines at its Sultanpur (Hyderabad) facility during the quarter.
• Production at the Panipat facility has doubled since operations commenced, supporting the company’s strategy to expand its footprint in North India.
• Management expects the additional capacity to drive future volume growth while improving manufacturing efficiency. 

Printing Optimisation Enhances Cost Efficiency:

• Following the successful removal of in-house printing bottlenecks, the company focused on improving logistics and printing operations across its manufacturing network.
  
• Strategic transportation planning and commercial negotiations significantly reduced road and air freight costs, which had increased in earlier quarters. At the same time, process improvements lowered printing wastage, contributing to better operational efficiency and cost optimisation. 

New Growth Opportunities and Customer Additions:

The company continued expanding its customer base by securing new business across Food and Pharmaceutical packaging.

New Customers Added

• Food Industry
  • Innovative Food
  • Alphonsa Cashew
  • Bakerville Specialities
  • Beejapuri Daily
  • DS Agrotech
  • Sam Flour & Spices
  • SGB Food
  • Veg Crop Agro
  • Several other customers

• Pharma Industry
  • Blackgoldust
  • Pharma Force Lab
  • Pure Source Nutrition Pvt. Ltd.
  • Topiox Research Centre Pvt. Ltd.
  • Several additional pharmaceutical customers

Management stated that these customer additions reflect the company’s growing reputation as a trusted packaging partner across multiple industries.

Expansion into High-Value Packaging Segments:

While maintaining its leadership in pails, Q-Packs and Thin Wall IML products, Mold-Tek is expanding its product portfolio into higher-value applications.

The company sees significant long-term opportunities in:

• Pharmaceutical packaging
• Diagnostic packaging
• Dosage pens
• Ophthalmic packaging
• Medical device packaging
• Electronics packaging
• Semiconductor packaging

These initiatives leverage Mold-Tek’s in-house expertise in mould manufacturing, robotics and In-Mould Labeling (IML) technology to diversify its revenue mix and strengthen its position in premium packaging solutions. 

Note:

• The press release highlights operational improvements, capacity expansion and customer additions but does not disclose capital expenditure details, revenue contribution from individual segments, order book, future financial guidance or expected investment returns from the planned expansion into new packaging categories. The press release highlights operational improvements, capacity expansion and customer additions but does not disclose capital expenditure details, revenue contribution from individual segments, order book, future financial guidance or expected investment returns from the planned expansion into new packaging categories. 

Risk Analysis

Summary:

• Mold-Tek Packaging maintained strong operational momentum during Q1 FY27 despite geopolitical disruptions and volatile input costs. While capacity expansion and operational efficiencies supported profitability, timely ramp-up of new facilities, sustained demand across end-user industries and stable raw material availability remain important for maintaining future growth. The company has not issued financial guidance for the remainder of FY27.

Key Risks:

• Demand in the Lubricant Packaging segment remained subdued due to supply disruptions linked to the Iran conflict, highlighting exposure to geopolitical events affecting customer operations. 
• Polymer prices and logistics costs remain susceptible to fluctuations, which could influence operating margins despite the company’s ability to pass on higher input costs. 
• Future growth depends on the successful utilisation of newly commissioned Pharma and Food & FMCG packaging capacities and continued customer acquisition. 
• The company has not disclosed revenue contribution, capital expenditure, expected returns or commercial timelines for its planned expansion into ophthalmic, medical device and electronics packaging. 

Worst Case:

• A prolonged slowdown in demand across key end-user industries or persistent supply chain disruptions could delay capacity utilisation improvements and moderate earnings growth.

Risk Level: Medium

Company Commentary

• Chairman & Managing Director Lakshman Rao stated that the company delivered a strong quarter despite geopolitical challenges, supported by higher capacity utilisation, improved operational efficiency and resilient demand across major business segments. 
• Management highlighted that the consolidation of Hyderabad manufacturing facilities has significantly improved productivity, reduced operating costs and contributed to achieving the company’s highest-ever EBITDA per kilogram. 
• The company reaffirmed its commitment to expanding its Pharma and Food & FMCG packaging businesses through capacity additions, technology-driven manufacturing and continued customer acquisition. 
• Management also emphasised its long-term strategy of increasing the contribution from high-value packaging segments, including ophthalmic, medical device, diagnostic and electronics packaging, to diversify the business and strengthen profitability.